Pancreatic Cancer Research

ResearcherHunan Normal UniversityActive in the last 2 years

Wei Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7570-9167; OpenAlex author ID A5014397451. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 5

  1. A Self-Calibrating Fluorescent-Photoacoustic Integrated Probe Enables Fast Visualizing Pancreatic Cancer and Imaging-Guided Tumor Surgery. Co-author DOI 10.1002/smll.202408527↗
  2. Active-Targeted ICG for Surgical Navigation and Fluorescence-Guided Laparoscopic Photothermal Ablation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.analchem.4c04575↗
  3. JS-K Combined with a Melanin-Based Theranostic Agent: A Novel Sequential Delivery Strategy to Enhance the Near-Infrared Fluorescence Imaging of Pancreatic Duct… Co-author DOI 10.1021/acs.analchem.3c04914↗
  4. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. Last author DOI 10.1016/j.biocel.2022.106358↗
  5. Endoscopically guided interventional photodynamic therapy for orthotopic pancreatic ductal adenocarcinoma based on NIR-II fluorescent nanoparticles. Co-author DOI 10.7150/thno.84164↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hong‐Wen Liu · 4 shared papers, 2023–2025 · strength 0.88
  2. Lei Zhou · 3 shared papers, 2024–2025 · strength 0.73
  3. Manxiong Dai · 3 shared papers, 2023–2025 · strength 0.64
  4. Kang Chen · 2 shared papers, 2024–2025 · strength 0.45
  5. Ning Zhou · 2 shared papers, 2023–2024 · strength 0.36
  6. Yan Liao · 2 shared papers, 2023 · strength 0.35
  7. Cong Hu · 1 shared paper, 2025 · strength 0.28
  8. Kang Chen · 1 shared paper, 2023 · strength 0.19
  9. Xu Chen · 1 shared paper, 2023 · strength 0.15
  10. Sulai Liu · 1 shared paper, 2023 · strength 0.15
  11. Kang Chen · 1 shared paper, 2023 · strength 0.15
  12. Guosheng Song · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.